Results 131 to 140 of about 47,001 (202)

Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study. [PDF]

Oncologist
El Zarif T, Abou Alaiwi S, Nassar AH, Gariazzo E, Santo V, Garbo E, Aldea M, Paoloni F, Pannu S, Semaan K, Chehab O, Hoballah M, Navani V, Gao Y, Meyers D, Stukalin I, Mittra A, Li M, Jones N, Grynberg S, Shapira R, Vasbinder A, Hayek SS, Bou Farhat E, Eid M, Saad E, Freeman D, Parikh K, Desai A, Smith C, El-Am E, Nana FA, Foderaro S, Baena J, Herrera M, Cortellini A, Pinato DJ, Korolewicz J, Kim C, Sackstein P, Denu RA, Macaron W, Abdel-Wahab N, Neilan TG, Lima JAC, Florez N, Janne P, Ricciuti B, Pecci F, Choueiri TK, Kwan JM, Naqash AR.   +51 more
europepmc   +1 more source

Optimal autofluorescence blocking for reliable immunofluorescence in human ovarian samples: A comparison of 4 blocking kits. [PDF]

Biochem Biophys Rep
Einenkel-Ulrich R, Schlingheider J, Färber CM, Schallmoser A, Sänger N.   +4 more
europepmc   +1 more source

CistromeMeta: a large language model powered tool for automated ChIP-seq metadata extraction. [PDF]

Bioinformatics
Piccaro N, Brown M, Meyer C.
europepmc   +1 more source

Lipid alterations in farber disease

, 2014
openaire   +2 more sources

TRADE: tolerability of adjuvant abemaciclib at 6 months after initial dose escalation in patients with early-stage HR-positive/HER2-negative breast cancer. [PDF]

ESMO Open
Schlam I, Trapani D, Kim SE, Heiling H, Faggen M, Sinclair N, Sanz-Altamira P, Battelli C, Berwick S, Lo S, Acevedo J, Sinclair S, Malcolm A, Varella L, Sammons S, Schumer S, Poorvu PD, Wallace E, Pasternak E, Tayob N, Tolaney SM, Mayer EL.   +21 more
europepmc   +1 more source

Risk-adapted therapy guided by human papillomavirus (HPV) circulating tumor DNA in HPV-positive oropharyngeal cancer (ReACT 1.0): an exploratory phase II trial. [PDF]

Nat Commun
Hanna GJ, Gupta TR, Trippa L, Rettig EM, Margalit DN, Tishler RB, Pashtan I, Kim E, Droznin A, Gunasti L, Maddox R, Minken J, Mukundan D, Sehgal K, Dennis MJ, O'Connor T, Qian JM, Boyd GH, Saraf A, Massiel Gil D, Sethi RK, Annino DJ, Goguen LA, Guenette JP, Bakhtiar M, Jo VY, Wong K, Uppaluri R, Haddad RI, Schoenfeld JD.   +29 more
europepmc   +1 more source

Antibody-drug conjugates in brain metastases: evidence outpacing trial design. [PDF]

ESMO Open
Sarfraz Z, Tarantino P, Mahtani R, Ahluwalia MS.   +3 more
europepmc   +1 more source

Ceramide toxicity in cardiomyocytes: from Farber disease to cardiovascular diseases

American Journal of Physiology-Heart and Circulatory Physiology
Lindsey A. Fitzsimons, Harilaos Filippakis   +1 more
openaire   +2 more sources